Despite concern about the negative impacts of globalisation on the economies of OECD regions, "Globalisation and Regional Economies" presents evidence that region-specific advantages remain a significant source of productivity gain for firms.
English, , 203kb
This note contrasts key findings for Japan with global trends among OECD countries, under the headings: quantity and quality challenges, equity challenges, and resource and efficiency challenges.
Enhancing the Role of SMEs in Global Value Chains, addresses how globalisation of value chains and of large enterprises affects the role of SMEs as traditional partners, suppliers or distributors for larger firms and explores the benefits of SME participation in global value chains.
English, , 38kb
This note, taken from Chapter 2 of Economic Policy Reforms: Going for Growth 2007, contains information about the progress in implementing reforms in line with the 2006 priorities for Japan.
"Competitive Regional Clusters: National Policy Approaches" analyses the objectives, targeting, instruments and inter-governmental role sharing used by 26 programmes in 14 OECD countries.
Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.
English, , 2,245kb
Floods and flood-related disasters, such as landslides, are a traditional and serious risk in Japan. In the 1940s and 50s, after flood disasters took thousands of lives, the creation of a comprehensive flood risk management programme led to a dramatic reduction in human casualties.
English, , 1,654kb
This Country Background Report for Japan was prepared by the Higher Education Bureau of the Ministry of Education, Culture, Sports, Science and Technology as an input to the OECD Thematic review of Tertiary Education.
This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.
This study shows how knowledge-intensive services activities (KISAs) contribute to the acquisition and growth capabilities of firms and public sector organisations.